BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15637892)

  • 1. [Damage of left ventricular function after treatment with doxorubicin in patients with malignant lymphomas].
    Elbl L; Chaloupka V; Vásová I; Nehyba S; Vorlícek J; Navrátil M; Kiss I; Cíhalová M
    Vnitr Lek; 2000 Nov; 46(11):768-75. PubMed ID: 15637892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in left ventricular function during chemotherapy with doxorubicin].
    Elbl L; Chaloupka V; Vásová I; Kiss I; Jancík J; Vorlícek J; Navrátil M
    Vnitr Lek; 1999 Jul; 45(7):395-402. PubMed ID: 11045157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.
    Elbl L; Hrstkova H; Chaloupka V; Novotny J; Michalek J
    Neoplasma; 2003; 50(3):191-7. PubMed ID: 12937852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma.
    Elbl L; Vasova I; Tomaskova I; Jedlicka F; Navratil M; Pospisil Z; Vorlicek J
    Neoplasma; 2006; 53(2):174-81. PubMed ID: 16575475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
    Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
    Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the cardioprotective effect of bispiperazinedione ICRF-187 (Cardioxane) in patients treated with anthracyclines--an echocardiographic study].
    Elbl L; Vásová I; Chaloupka V; Hájek R; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):268-73. PubMed ID: 8693714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of left ventricular function in patients with mammary carcinoma after treatment with epidoxorubicin using a high-dose, short-term protocol].
    D'Alto M; Maurea S; Basso A; Polverino W; Bianchi U; Bonelli A; Silvestro P; Salvatore M; Chiariello M
    Cardiologia; 1997 Jun; 42(6):611-8. PubMed ID: 9289377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic possibilities of late cardiotoxic sequelae of chemotherapy with anthracyclines].
    Elbl L; Hrstková H; Chaloupka V; Novotný J
    Vnitr Lek; 2002 Oct; 48(10):981-8. PubMed ID: 16737150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
    de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
    Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Echocardiographic detection of adriamycin cardiotoxicity. Study of the relationship between the shortening fraction-constraint and the systolic shortening fraction-diameter of the left ventricle].
    Boujon B; Lechat P; Mantz J; Fraysse JB; Leblond V; Drobinski G; Lascault G; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1989 Feb; 82(2):167-75. PubMed ID: 2500077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
    Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelin-1 in the development of a special type of cardiomyopathy.
    Zsáry A; Szücs S; Schneider T; Rosta A; Sármán P; Fenyvesi T; Karádi I
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():272S-275S. PubMed ID: 12193102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
    Nagy AC; Tolnay E; Nagykálnai T; Forster T
    Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.
    Lunning MA; Kutty S; Rome ET; Li L; Padiyath A; Loberiza F; Bociek RG; Bierman PJ; Vose JM; Armitage JO; Porter TR
    Am J Clin Oncol; 2015 Aug; 38(4):377-81. PubMed ID: 24192805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
    Kuittinen T; Husso-Saastamoinen M; Sipola P; Vuolteenaho O; Ala-Kopsala M; Nousiainen T; Jantunen E; Hartikainen J
    Bone Marrow Transplant; 2005 Dec; 36(12):1077-82. PubMed ID: 16247436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.